The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts
Open accessAbstract
It is established that the interaction between microenvironment and cancer cells has a critical role in tumor development, given the dependence of neoplastic cells on stromal support. However, how this communication promotes the activation of normal (NFs) into cancer-associated fibroblasts (CAFs) is still not well understood. Most microRNA (miRNA) studies focused on tumor cell, but there is increasing evidence of their involvement in reprogramming NFs into CAFs. Here we show that miR-9, upregulated in various breast cancer cell lines and identified as pro-metastatic miRNA, affects the properties of human breast fibroblasts, enhancing the switch to CAF phenotype, thus contributing to tumor growth. Expressed at higher levels in primary triple-negative breast CAFs versus NFs isolated from patients, miR-9 improves indeed migration and invasion capabilities when transfected in immortalized NFs; viceversa, these properties are strongly impaired in CAFs upon miR-9 inhibition. We also demonstrate that tumor-secreted miR-9 can be transferred via exosomes to recipient NFs and this uptake results in enhanced cell motility. Moreover, we observed that this miRNA is also secreted by fibroblasts and in turn able to alter tumor cell behavior, by modulating its direct target E-cadherin, and NFs themselves. Consistently with the biological effects observed, gene expression profiles of NFs upon transient transfection with miR-9 show the modulation of genes mainly involved in cell motility and extracellular matrix remodeling pathways. Finally, we were able to confirm the capability of NFs transiently transfected with miR-9 to promote in vivo tumor growth. Taken together, these data provide new insights into the role of miR-9 as an important player in the cross-talk between cancer cells and stroma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
Adjusting batch effects in microarray expression data using empirical Bayes methods
Johnson, W. E., Li, C., & Rabinovic, A. (2007) · Biostatistics · doi:10.1093/biostatistics/kxj037 · Cited by 8,658
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer
Ma, L., Teruya-Feldstein, J., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06174 · Cited by 2,605
lumi: a pipeline for processing Illumina microarray
Du, P., Kibbe, W. A., & Lin, S. M. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn224 · Cited by 2,019
MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review
Iorio, M. V., & Croce, C. M. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100209 · Cited by 1,739
Self-citationStromal gene expression predicts clinical outcome in breast cancer
Finak, G., Bertos, N., Pepin, F., Sadekova, S., Souleimanova, M., Zhao, H., Chen, H., Omeroglu, G., Meterissian, S., Omeroglu, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1764 · Cited by 1,687
Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis
Zhou, W., Fong, M. Y., Min, Y., Somlo, G., Liu, L., Palomares, M. R., Yu, Y., Chow, A., O’Connor, S. T. F., Chin, A. R., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.03.007 · Cited by 1,476 · cited 1×
“Their extracellular presence as the major RNA component of exosomes suggests an internalization process by TME cells, thus mediating the cancer–host communication and participating in cancer metastasis by adapting the cell niches.(12) To date, little is known about miRNA expression differences between CAFs and NFs.”
miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis
Ma, L., Young, J., Prabhala, H., Pan, E., Mestdagh, P., Muth, D., Teruya-Feldstein, J., Reinhardt, F., Onder, T. T., Valastyan, S., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2024 · Cited by 1,336
Molecular characterization of the tumor microenvironment in breast cancer
Allinen, M., Beroukhim, R., Cai, L., Brennan, C., Lahti-Domenici, J., Huang, H., Porter, D., Hu, M., Chin, L., Richardson, A., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.010 · Cited by 1,299
Stromal Fibroblasts in Cancer: A Novel Tumor-Promoting Cell Type
Orimo, A., & Weinberg, R. A. (2006) · Cell Cycle · doi:10.4161/cc.5.15.3112 · Cited by 799
Triple-negative breast cancer: epidemiological considerations and recommendations
Boyle, P. (2012) · Annals of Oncology · doi:10.1093/annonc/mds187 · Cited by 593
Frozen robust multiarray analysis (fRMA)
McCall, M. N., Bolstad, B. M., & Irizarry, R. A. (2010) · Biostatistics · doi:10.1093/biostatistics/kxp059 · Cited by 590
Zhuang, G., Wu, X., Jiang, Z., Kasman, I., Yao, J., Guan, Y., Oeh, J., Modrusan, Z., Bais, C., Sampath, D., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.183 · Cited by 471
MicroRNAs Reprogram Normal Fibroblasts into Cancer-Associated Fibroblasts in Ovarian Cancer
Mitra, A. K., Zillhardt, M., Hua, Y., Tiwari, P., Murmann, A. E., Peter, M. E., & Lengyel, E. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0206 · Cited by 371
MicroRNAs and chromosomal abnormalities in cancer cells
Calin, G. A., & Croce, C. M. (2006) · Oncogene · doi:10.1038/sj.onc.1209910 · Cited by 263
Molecular signatures suggest a major role for stromal cells in development of invasive breast cancer
Casey, T., Bond, J., Tighe, S., Hunter, T., Lintault, L., Patel, O., Eneman, J., Crocker, A., White, J., Tessitore, J., et al. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-9982-8 · Cited by 211
Stromal miR-200s contribute to breast cancer cell invasion through CAF activation and ECM remodeling
Tang, X., Hou, Y., Yang, G., Wang, X., Tang, S., Du, Y.-E., Yang, L., Yu, T., Zhang, H., Zhou, M., et al. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2015.78 · Cited by 200
Breast Cancer-Associated Fibroblasts: Where We Are and Where We Need to Go
Buchsbaum, R., & Oh, S. (2016) · Cancers · doi:10.3390/cancers8020019 · Cited by 183
Heterogeneity of gene expression in stromal fibroblasts of human breast carcinomas and normal breast
Bauer, M., Su, G., Casper, C., He, R., Rehrauer, W., & Friedl, A. (2010) · Oncogene · doi:10.1038/onc.2009.463 · Cited by 172
The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts
Aprelikova, O. N., Xiang, Y., Palla, J. B., Wei, B., John, S., Yi, M., Stephens, R. M., Simpson, R. J., Risinger, J. I., Jazaeri, A. A., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.21.13674 · Cited by 152
Gwak, J. M., Kim, H. J., Kim, E. J., Chung, Y. R., Yun, S., Seo, A. N., Lee, H. J., & Park, S. Y. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3069-5 · Cited by 136
Angelucci, C., Maulucci, G., Lama, G., Proietti, G., Colabianchi, A., Papi, M., Maiorana, A., Spirito, M. D., Micera, A., Balzamino, B. O., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050804 · Cited by 119
MiRNA expression analysis of cancer-associated fibroblasts and normal fibroblasts in breast cancer
Zhao, L., Sun, Y., Hou, Y., Peng, Q., Wang, L., Luo, H., Tang, X., Zeng, Z., & Liu, M. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.08.005 · Cited by 118
Functional subsets of mesenchymal cell types in the tumor microenvironment
Cortez, E., Roswall, P., & Pietras, K. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.12.010 · Cited by 112
Proteolytic and non-proteolytic roles of membrane type-1 matrix metalloproteinase in malignancy
Strongin, A. Y. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.04.009 · Cited by 110
Peng, Q., Zhao, L., Hou, Y., Sun, Y., Wang, L., Luo, H., Peng, H., & Liu, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060321 · Cited by 93
Sadr‐Nabavi, A., Ramser, J., Volkmann, J., Naehrig, J., Wiesmann, F., Betz, B., Hellebrand, H., Engert, S., Seitz, S., Kreutzfeld, R., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.24108 · Cited by 87
Qiao, A., Gu, F., Guo, X., Zhang, X., & Fu, L. (2016) · Frontiers of Medicine · doi:10.1007/s11684-016-0431-5 · Cited by 86
Park, S. Y., Kim, H. M., & Koo, J. S. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3291-9 · Cited by 84
Rozenchan, P. B., Carraro, D. M., Brentani, H., Mota, L. D. D. C., Bastos, E. P., Ferreira, E. N., Torres, C., Katayama, M. L. H., Roela, R. A., de Lyra, E. C., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24646 · Cited by 63
Role of secreted type I collagen derived from stromal cells in two breast cancer cell lines
Kim, S. H., Lee, H. Y., Jung, S. P., Kim, S., Lee, J. E., Nam, S. J., & Bae, J. W. (2014) · Oncology Letters · doi:10.3892/ol.2014.2199 · Cited by 49
Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment
Tian, H., Liu, J., Chen, J., Gatza, M. L., & Blobe, G. C. (2015) · Oncogene · doi:10.1038/onc.2015.13 · Cited by 49
Absence of feedback regulation in the synthesis of COL1A1
Dzobo, K., Leaner, V. D., & Parker, M. I. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.03.006 · Cited by 20
Cited by
Exosomes: key players in cancer and potential therapeutic strategy
Dai, J., Su, Y., Zhong, S., Cong, L., Liu, B., Yang, J., Tao, Y., He, Z., Chen, C., & Jiang, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00261-0 · Cited by 1,186
The hypoxic tumour microenvironment
Petrova, V., Annicchiarico-Petruzzelli, M., Melino, G., & Amelio, I. (2018) · Oncogenesis · doi:10.1038/s41389-017-0011-9 · Cited by 1,019
Maacha, S., Bhat, A. A., Jimenez, L., Raza, A., Haris, M., Uddin, S., & Grivel, J.-C. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0965-7 · Cited by 572
Exosomes in cancer development and clinical applications
Tai, Y., Chen, K., Hsieh, J., & Shen, T. (2018) · Cancer Science · doi:10.1111/cas.13697 · Cited by 426
Roles and mechanisms of exosomal non-coding RNAs in human health and diseases
Li, C., Ni, Y.-Q., Xu, H., Xiang, Q.-Y., Zhao, Y., Zhan, J.-K., He, J.-Y., Li, S., & Liu, Y.-S. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00779-x · Cited by 406
Metadata
- Authors
- Baroni, S., Romero-Cordoba, S., Plantamura, I., Dugo, M., D’Ippolito, E., Cataldo, A., Cosentino, G., Angeloni, V, Rossini, A., Daidone, M. G., & Iorio, M. V.
- Venue
- Cell Death & Disease
- Published
- 2016-07-28
- Volume
- 7
- Issue
- 7
- Pages
- e2312-e2312
- ISSN
- 2041-4889 (ISSN-L)
- OpenAlex
- W2507020595
- Cited by
- 306
- References
- 37
- FWCI
- 9.22
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.